← Eichor
Condition: Mesothelioma Malignant Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mesothelioma Malignant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · 26 location(s) · Tango Therapeutics, Inc. · NCT05732831Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
NA · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04024917Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Phase 1/Phase 2 · 12 location(s) · Vivace Therapeutics, Inc · NCT04665206First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT05304208Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Phase 2 · 132 location(s) · Alliance for Clinical Trials in Oncology · NCT05647265A Study of Sacituzumab Govitecan in People With Mesothelioma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06477419Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NA · 1 location(s) · Brigham and Women's Hospital · NCT06538376EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility
NA · 2 location(s) · NHS Greater Glasgow and Clyde · NCT06491784Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Phase 1/Phase 2 · 66 location(s) · Genmab · NCT05579366Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Phase N/A · 1 location(s) · Oslo University Hospital · NCT02073500NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a F
Phase 1/Phase 2 · 1 location(s) · University Hospital, Antwerp · NCT07121374Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and T
Phase N/A · 1 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06637345New Preclinical and Clinical Approaches to Mesothelioma
Phase N/A · 2 location(s) · Marco Emilio Bianchi · NCT06536179A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
Phase N/A · 1 location(s) · University College, London · NCT05628376Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03830229Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · 97 location(s) · AstraZeneca · NCT0653560718F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01950572Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03760575Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
NA · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06907095
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.